These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18514351)

  • 1. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.
    Martinez M; Rathbone M; Burgess D; Huynh M
    J Control Release; 2008 Jul; 129(2):79-87. PubMed ID: 18514351
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained release veterinary parenteral products.
    Medlicott NJ; Waldron NA; Foster TP
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure.
    Dokoumetzidis A; Macheras P
    J Control Release; 2008 Jul; 129(2):76-8. PubMed ID: 18538435
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast Dissolving/Disintegrating Dosage Forms: Growth from Immediate Release to Sustained Release and Traditional Medicines.
    Saharan VA; Singh A
    Recent Pat Drug Deliv Formul; 2015; 9(3):189-91. PubMed ID: 26022667
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissolution test development for complex veterinary dosage forms: oral boluses.
    Fahmy R; Marnane B; Bensley D; Hollenbeck RG
    AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI; Hussain MA
    J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of Konjac glucomannan as novel excipients for floating systems.
    Ji Y; Deng Y
    J Control Release; 2011 Nov; 152 Suppl 1():e34-6. PubMed ID: 22195909
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
    Cai J; Zhang Y; Du W; Nan K
    J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
    [No Abstract]   [Full Text] [Related]  

  • 13. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery.
    Tamilvanan S; Venkatesh Babu R; Kannan K; Basu SK; Sa B
    PDA J Pharm Sci Technol; 2008; 62(2):125-54. PubMed ID: 18540538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2014 Jan; 36(211):54-8. PubMed ID: 24645581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution.
    Rost E
    Int J Pharm Compd; 2016; 20(6):526-527. PubMed ID: 28339393
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic modeling on drug release from controlled drug delivery systems.
    Dash S; Murthy PN; Nath L; Chowdhury P
    Acta Pol Pharm; 2010; 67(3):217-23. PubMed ID: 20524422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.